Evidence mapPaperPMID 42484789Full record

ArticleMolecular and cellular biochemistry2026

The METTL3/TRIM37 axis contributes to the progression of non-alcoholic fatty liver disease by promoting CAV1 degradation.

Lingyun Geng, Xiaoxu Han, Zhaoxia Du, Man Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lingyun Geng *Health Management Center,, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Xiaoxu Han *Department of General Practice, The Second Qilu Hospital of Shandong University, Jinan, China.
Zhaoxia DuDepartment of Reproductive Medicine, Qingdao Municipal Hospital, Qingdao, China.
Man JiangDepartment of Geriatrics,, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No. 324, Jingwuwei Qi Road, Jinan, 250021, China. jm4612@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caveolin-1 (CAV1), a principal structural component of caveolae, plays a pivotal role in the regulation of lipid metabolism, signal transduction, and cellular homeostasis. Dysregulation of CAV1 has been implicated in the pathogenesis of metabolic diseases, particularly non-alcoholic fatty liver disease (NAFLD). However, the precise molecular mechanisms responsible for CAV1 in NAFLD remain largely unclear. In vitro experiments were performed using THLE-3 or HepG2 cells treated with palmitic acid (PA) to establish a lipotoxic model. Quantitative real-time polymerase chain reaction was used to detect mRNA levels, whereas western blotting was performed to analyze protein expression. Cell viability, proliferation, apoptosis, and lipid deposition were assessed using Cell Counting Kit-8 (CCK-8), 5-ethynyl-2'-deoxyuridine (EdU), flow cytometry, and Oil Red O staining, respectively. Ferroptosis was evaluated by measuring Fe

Indexed as

Caveolin-1m6A methyltransferase-like 3Non-alcoholic fatty liver diseaseTripartite motif containing 37

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.